Transcriptome Analysis of Responses to Rhodomyrtone in Methicillin-Resistant Staphylococcus aureus

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Sianglum, Wipawadee ^a   Srimanote, Potjanee ^b   Taylor, Peter W ^c   Rosado, Helena ^c   Voravuthikunchai, Supayang P ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b THAMMASAT UNIVERSITY   (Thailand)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ANTIBIOTIC AGENT; DIAMINOPIMELIC ACID; LYSINE; PEPTIDOGLYCAN; PLANT MEDICINAL PRODUCT; RHODOMYRTONE; RNA 16S; TRANSCRIPTOME; UNCLASSIFIED DRUG;

AMINO ACID COMPOSITION; AMINO ACID SYNTHESIS; ANTIBACTERIAL ACTIVITY; ARGG GENE; ARTICLE; ASD GENE; BACTERIAL GENE; CARBOHYDRATE SYNTHESIS; CONTROLLED STUDY; DAPA GENE; DAPD GENE; FTSH GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INDUCTION; GENE REPRESSION; GENETIC CODE; KDPF GENE; LIPOPROTEIN METABOLISM; LYSA GENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROARRAY ANALYSIS; MURE GENE; NONHUMAN; NUCLEOTIDE METABOLISM; OPERON; PHENOTYPE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RPOB GENE; SAR0437 GENE; SAR0761 GENE; SAR0996 GENE; SCDA GENE; SIGB GENE; THRC GENE;

BASE SEQUENCE; DNA PRIMERS; GENE EXPRESSION REGULATION, BACTERIAL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROSCOPY, ELECTRON, SCANNING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTOME; XANTHONES;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; RHODOMYRTUS TOMENTOSA;

EID: 84866919783     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045744     Document Type: Article

References (32)

1. Chambers HF, (1988) Methicillin-resistant staphylococci. Clin Microbiol Rev 1: 173-186.
2. Wenzel RP, Bearman G, Edmond MB, (2007) Community-acquired methicillin-resistant Staphylococcus aureus (MRSA): new issues for infection control. Int J Antimicrob Agents 30: 210-212.
3. Lyon BR, Skurray R, (1987) Antimicrobial resistance of Staphylococcus aureus: genetic basis. Microbiol Rev 51: 88-134.
4. Aksoy DY, Unal S, (2008) New antimicrobial agents for the treatment of Gram-positive bacterial infections. Clin Microbiol Infect 14: 411-420.
5. Eliopoulos GM, (2009) Microbiology of drugs for treating multiply drug-resistant Gram-positive bacteria. J Infect 59Suppl 1: S17-24.
6. Shakil S, Akram M, Khan AU, (2008) Tigecycline: a critical update. J Chemother 20: 411-419.
7. Sorlozano A, Gutierrez J, Martinez T, Yuste ME, Perez-Lopez JA, et al. (2010) Detection of new mutations conferring resistance to linezolid in glycopeptide-intermediate susceptibility Staphylococcus hominis subspecies hominis circulating in an intensive care unit. Eur J Clin Microbiol Infect Dis 29: 73-80.
8. Bradley JS, (2005) Newer antistaphylococcal agents. Curr Opin Pediatr 17: 71-77.
9. Gibbons S, (2004) Anti-staphylococcal plant natural products. Nat Prod Rep 21: 263-277.
10. Sass V, Pag U, Tossi A, Bierbaum G, Sahl HG, (2008) Mode of action of human beta-defensin 3 against Staphylococcus aureus and transcriptional analysis of responses to defensin challenge. Int J Med Microbiol 298: 619-633.
11. Martin KW, Ernst E, (2003) Herbal medicines for treatment of bacterial infections: a review of controlled clinical trials. J Antimicrob Chemother 51: 241-246.
12. Cowan MM, (1999) Plant products as antimicrobial agents. Clin Microbiol Rev 12: 564-582.
13. Samy RP, Gopalakrishnakone P (2008) Therapeutic Potential of Plants as Anti-microbials for Drug Discovery. Evid Based Complement Alternat Med: 283-294.
14. Dachriyanus Salni, Sargent MV, Skelton BW, Soediro I, et al. (2002) Rhodomyrtone, an antibiotic from Rhodomyrtus tomentosa. Aust J Chem 55: 229-232.
15. Hiranrat A, Mahabusarakam W, (2008) New acylphloroglucinols from the leaves of Rhodomyrtus tomentosa. Tetrahedron 64: 11193-11197.
16. Limsuwan S, Trip EN, Kouwen TR, Piersma S, Hiranrat A, et al. (2009) Rhodomyrtone: a new candidate as natural antibacterial drug from Rhodomyrtus tomentosa. Phytomedicine 16: 645-651.
17. Saising J, Hiranrat A, Mahabusarakam W, Ongsakul M, Voravuthikunchai SP, (2008) Rhodomyrtone from Rhodomyrtus tomentosa (Aiton) Hassk. as a Natural Antibiotic for Staphylococcal Cutaneous Infections. Journal of Health Science 54: 589-595.
18. Sianglum W, Srimanote P, Wonglumsom W, Kittiniyom K, Voravuthikunchai SP, (2011) Proteome analyses of cellular proteins in methicillin-resistant Staphylococcus aureus treated with rhodomyrtone, a novel antibiotic candidate. PLoS One 6: e16628.
19. Bernal P, Zloh M, Taylor PW, (2009) Disruption of D-alanyl esterification of Staphylococcus aureus cell wall teichoic acid by the {beta}-lactam resistance modifier (-)-epicatechin gallate. J Antimicrob Chemother 63: 1156-1162.
20. Clinical and Laboratory standards Institute (2005) Performance standards for antimicrobial susceptibility testing: Fifteenth Informational Supplement. M100-S15. Wayne, PA: CLSI.
21. Doyle M, Feuerbaum EA, Fox KR, Hinds J, Thurston DE, et al. (2009) Response of Staphylococcus aureus to subinhibitory concentrations of a sequence-selective, DNA minor groove cross-linking pyrrolobenzodiazepine dimer. J Antimicrob Chemother 64: 949-959.
22. Witney AA, Marsden GL, Holden MT, Stabler RA, Husain SE, et al. (2005) Design, validation, and application of a seven-strain Staphylococcus aureus PCR product microarray for comparative genomics. Appl Environ Microbiol 71: 7504-7514.
23. Stranden AM, Ehlert K, Labischinski H, Berger-Bachi B, (1997) Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin- resistant Staphylococcus aureus. J Bacteriol 179: 9-16.
24. van Heijenoort J, (2001) Recent advances in the formation of the bacterial peptidoglycan monomer unit. Nat Prod Rep 18: 503-519.
25. Rodionov DA, Vitreschak AG, Mironov AA, Gelfand MS, (2003) Regulation of lysine biosynthesis and transport genes in bacteria: yet another RNA riboswitch? Nucleic Acids Res 31: 6748-6757.
26. Pavelka MS Jr, Jacobs WR Jr, (1996) Biosynthesis of diaminopimelate, the precursor of lysine and a component of peptidoglycan, is an essential function of Mycobacterium smegmatis. J Bacteriol 178: 6496-6507.
27. Formstone A, Carballido-Lopez R, Noirot P, Errington J, Scheffers DJ, (2008) Localization and interactions of teichoic acid synthetic enzymes in Bacillus subtilis. J Bacteriol 190: 1812-1821.
28. Jonsson K, McDevitt D, McGavin MH, Patti JM, Hook M, (1995) Staphylococcus aureus expresses a major histocompatibility complex class II analog. J Biol Chem 270: 21457-21460.
29. Camargo IL, Neoh HM, Cui L, Hiramatsu K, (2008) Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype. Antimicrob Agents Chemother 52: 4289-4299.
30. Delaune A, Poupel O, Mallet A, Coic YM, Msadek T, et al. (2011) Peptidoglycan crosslinking relaxation plays an important role in Staphylococcus aureus WalKR-dependent cell viability. PLoS One 6: e17054.
31. Brunskill EW, de Jonge BL, Bayles KW, (1997) The Staphylococcus aureus scdA gene: a novel locus that affects cell division and morphogenesis. Microbiology 143 (Pt 9): 2877-2882.
32. Barreteau H, Kovac A, Boniface A, Sova M, Gobec S, et al. (2008) Cytoplasmic steps of peptidoglycan biosynthesis. FEMS Microbiol Rev 32: 168-207.